Evaluation of dyspnea in the elderly

Clinics in Geriatric Medicine

Volumn 19, Issue 1, 2003, Pages 19-33

  Mahler, Donald A ^a   Fierro Carrion, Gustavo ^a   Baird, John C ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CODEINE; IPRATROPIUM BROMIDE; MORPHINE; NARCOTIC AGENT; SALBUTAMOL;

AGE; AGED; AGING; ANAMNESIS; ASTHMA; BEHAVIOR THERAPY; BREATHING EXERCISE; BREATHING MUSCLE; CHEMORECEPTOR; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; CONGESTIVE HEART FAILURE; CONSTIPATION; COPING BEHAVIOR; CYSTIC FIBROSIS; DIAGNOSTIC APPROACH ROUTE; DROWSINESS; DRUG INDICATION; DRUG INDUCED DISEASE; DYSPNEA; EXERCISE; EXPERIENCE; HUMAN; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; LUNG RECEPTOR; MECHANORECEPTOR; MEDICAL SOCIETY; PHYSICAL EXAMINATION; QUALITATIVE ANALYSIS; REVIEW; SYMPTOM; SYNDROME DELINEATION; TREATMENT INDICATION; WHEEZING;

AGED; AGING; CHRONIC DISEASE; DYSPNEA; EXERCISE; HUMANS; PHYSICAL EXAMINATION; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES;

EID: 0037291536     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(02)00050-2     Document Type: Review

References (37)

1. Harver A, Mahler DA. Dyspnea: Sensation, symptom, and illness. In: Mahler DA, editor. Dyspnea (Lung Biology in Health and Disease, Vol. III). New York: Marcel Dekker; 1998. p. 1-35.
2. Wright GW, Branscomb BV. Origin of the sensations of dyspnea. Trans Am Clin Climatol Assoc 1954;1966:116-25.
3. Schwartzstein RM, Manning HL, Weiss JW, et al. Dyspnea: A sensory experience. Lung 1990;168:185-99.
4. American Thoracic Society. Dyspnea-mechanisms, assessment, and management. A consensus statement. Am J Respir Crit Care Med 1999;159:321-40.
5. Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in patients with cardiorespiratory diseases. Am J Respir Crit Care Med 1996;154:1357-61.
6. Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990;142:1009-14.
7. Boezen HM, Rijcken B, Schouten JP, et al. Breathlessness in elderly individuals is related to low lung function and reversibility of airway obstruction. Eur Respir J 1998;12:805-10.
8. Dow L, Coggon D, Osmond C, et al. A population survey of respiratory symptoms in the elderly. Eur Respir J 1991;4:267-72.
9. Horsley JR, Sterling IJ, Waters WE, Howell JB. Respiratory symptoms among elderly people in the New Forest area as assessed by postal questionnaire. Age Ageing 1991;20:325-31.
10. Renwick DS, Connolly MJ. Do respiratory symptoms predict chronic airflow obstruction and bronchial hyperresponsiveness in older adults? J Gerontol 1999;54A:M136-9.
11. Manning HL, Schwartzstein RM. Pathophysiology of dyspnea. N Engl J Med 1995;333:1547-53.
12. Manning HL, Mahler DA, Harver A. Dyspnea in the elderly. In: Mahler DA, editor. Pulmonary Disease in the Elderly Patient (Lung Biology in Health and Disease, Vol. 63). New York: Marcel Dekker; 1993. p. 81-112.
13. Campbell EJM, Howell JBL. The sensation of breathlessness. Br Med Bull 1963;19:36-40.
14. O'Donnell DE. Exertional breathlessness in chronic respiratory disease. In: Mahler DA, editor. Dyspnea (Lung Biology in Health and Disease, Vol. III). New York: Marcel Dekker; 1998. p. 97-148.
15. Knudson RJ. How aging affects the normal adult lung. J Respir Dis 1981;2:74-84.
16. Mahler DA, Rosiello RA, Loke J. The aging lung. Clin Geriatr Med 1986;2:215-25.
17. Mahler DA, Mejia-Alfaro R, Ward J, et al. Continuous measurement of breathlessness during exercise: Validity, reliability, and responsiveness. J Appl Physiol 2001;90:2188-96.
18. 2. J Appl Physiol 1984;56:1143-50.
19. Mahler DA. Diagnosis of dyspnea. In: Mahler DA, editor. Dyspnea (Lung Biology in Health and Disease, Vol. III). New York: Marcel Dekker, 1998. p. 221-60.
20. Masotti L, Ceccarelli E, Cappelli R, et al. Pulmonary embolism in the elderly: Clinical, instrumental and laboratory aspects. Gerontology 2000;46:205-11.
21. Flaherty KR, Wald J, Weisman IM, et al. Unexplained exertional limitation: Characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 2001;164:425-32.
22. Weisman IM, Zeballos RJ. Clinical evaluation of unexplained dyspnea. Cardiologia 1996;41:621-34.
23. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:967-75.
24. Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002;19:217-24.
25. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvemnet in exercise performance after anticholingeric therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:542-9.
26. ZuWallack RL, Mahler DA, Reilly D, et al. Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest 2001;119:1661-70.
27. Tantucci C, Duguet A, Similowski T, et al. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998;12:799-804.
28. Carrieri-Kohlman V, Gormley JM. Coping strategies for dyspnea. In: Mahler DA, editor. Dyspnea (Lung Biology in Health and Disease Vol. III). New York: Marcel Dekker; 1998. p. 287-313.
29. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based guidelines. Chest 1997;112:1363-96.
30. American Thoracic Society. Pulmonary rehabilitation-1999; Am J Respir Crit Care Med 1999;159:1666-82.
31. Horowitz MB, Littenberg B, Mahler DA. Dyspnea ratings for prescribing exercise intensity in patients with chronic obstructive pulmonary disease. Chest 1996;109:1169-75.
32. Mejia R, Ward J, Lentine T, et al. Target dyspnea ratings predict expected oxygen consumption as well as target heart rate values. Am J Respir Crit Care Med 1999;159:1485-9.
33. Simpson K, Killian K, McCartney N, et al. Randomised controlled trial of weight lifting exercise in patients with chronic airflow limitation. Thorax 1992;47:70-5.
34. Harver A, Mahler DA, Daubenspeck JA. Targeted inspiratory, muscle training improves respiratory muscle function and reduces dyspnea in patients with chronic obstructive pulmonary disease. Ann Intern Med 1989;111:117-24.
35. Lisboa C, Munoz V, Beroiza T. Inspiratory muscle training in chronic airflow limitation: Comparison of two different training loads with a threshold device. Eur Respir J 1994;7:1266-74.
36. Luce JM, Luce JA. Management of dyspnea in patients with far-advanced lung disease. JAMA 2001;285:1331-7.
37. Mazzacato C, Buclin T, Rapin C-H. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trial. Ann Oncol 1999;10:1511-4.